MOS
WST icon

MGO One Seven’s West Pharmaceutical WST Stock Holding History

MGO One Seven’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$627K Buy
1,745
+919
+111% +$281K 0.01% 874
2026
Q1 		$207K Buy
826
+28
+4% +$6.97K ﹤0.01% 1325
2025
Q4 		$220K Buy
+798
New +$218K ﹤0.01% 1281
2025
Q1 		– Sell
-1,277
Closed -$418K – 1201
2024
Q4 		$418K Buy
1,277
+54
+4% +$17K 0.02% 699
2024
Q3 		$367K Sell
1,223
-131
-10% -$40.1K 0.02% 692
2024
Q2 		$446K Buy
1,354
+17
+1% +$6.01K 0.02% 599
2024
Q1 		$529K Sell
1,337
-284
-18% -$105K 0.03% 501
2023
Q4 		$571K Sell
1,621
-153
-9% -$54.1K 0.03% 471
2023
Q3 		$666K Sell
1,774
-63
-3% -$24.4K 0.05% 355
2023
Q2 		$703K Sell
1,837
-76
-4% -$27.1K 0.06% 328
2023
Q1 		$663K Buy
1,913
+35
+2% +$10.2K 0.04% 400
2022
Q4 		$442K Sell
1,878
-228
-11% -$54K 0.04% 433
2022
Q3 		$518K Sell
2,106
-176
-8% -$53.6K 0.02% 383
2022
Q2 		$690K Sell
2,282
-160
-7% -$52.1K 0.1% 241
2022
Q1 		$1M Sell
2,442
-201
-8% -$78.7K 0.11% 209
2021
Q4 		$1.24M Buy
2,643
+143
+6% +$61.6K 0.13% 190
2021
Q3 		$1.07M Sell
2,500
-158
-6% -$66.6K 0.14% 187
2021
Q2 		$954K Buy
2,658
+177
+7% +$58.5K 0.13% 186
2021
Q1 		$699K Buy
2,481
+11
+0.4% +$3.15K 0.12% 218
2020
Q4 		$700K Buy
2,470
+32
+1% +$8.98K 0.14% 186
2020
Q3 		$670K Buy
+2,438
New +$645K 0.16% 164
2019
Q1 		– Sell
-195
Closed -$19K – 1646
2018
Q4 		$19K Buy
+195
New +$21.2K 0.01% 942
2018
Q1 		$17K Hold
195
– – 0.01% 933
2017
Q4 		$19K Buy
+195
New +$19.1K 0.01% 889

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MGO One Seven's WST Position: Q2 2026 in Review

MGO One Seven increased its West Pharmaceutical (WST) stake by 111% in Q2 2026, buying an estimated $281K and bringing the position to 1,745 shares worth $627K. The position accounts for 0.01% of the portfolio, ranked #874.

MGO One Seven first reported a position in WST in Q4 2017 and has held it in 24 quarters since. The position peaked at $1.24M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • MGO One Seven held 1,745 shares of West Pharmaceutical worth $627K as of Q2 2026.
  • MGO One Seven bought 919 West Pharmaceutical shares in Q2 2026, an estimated $281K.
  • West Pharmaceutical made up 0.01% of MGO One Seven's portfolio in Q2 2026, its #874 holding.
  • MGO One Seven first reported a position in West Pharmaceutical in Q4 2017 and has held it in 24 quarters since.
  • MGO One Seven's West Pharmaceutical position peaked at $1.24M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.